In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) ...
Key Points Interested in AbCellera Biologics Inc.? Here are five stocks we like better. AbCellera is pivoting from a ...
Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental ...
The buyout hands J&J a technology that merges elements of two popular drugmaking methods: protein degraders and antibody-drug ...
A new study tracking thousands of B cells across more than 100 germinal centers in mice reveals how the system consistently ...
Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodies Complete blockade of TL1A ...
Optimizing elution buffers with specific salt additives could be a viable strategy to enhance the efficiency of ...
Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in ...
Scientists have long worried about the reliability of commercial antibodies, and the latest findings have sparked fresh concerns.
MedPage Today on MSN
Decnupaz Approved for Rare Blood Cancer
Complete remission rate of 69% in blastic plasmacytoid dendritic cell neoplasm ...
Today at the 6th International Veterinary Pain Short Course hosted at NC State College of Veterinary Medicine, VetrixBio ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results